School of Medicine
Showing 51-57 of 57 Results
-
Aaran Vijayakumaran
Postdoctoral Scholar, Ophthalmology
BioAaran Vijayakumaran, PhD is a Postdoctoral Scholar at Stanford University School of Medicine, where he researches the cell biology of inherited Parkinson’s Disease in the Department of Biochemistry under Professor Suzanne Pfeffer.
He completed his PhD at the University of Cambridge, applying volumetric electron microscopy and deep-learning based image segmentation to generate the first nanoscale map of the human airway epithelium. His doctoral work revealed how cellular architecture and metabolism remodel during differentiation, with a particular focus on the motile cilia, their rootlets, and their structural contacts with mitochondria and the consequences for mitochondrial metabolism. Beyond research, Aaran is active in the biotech and innovation ecosystem. He was awarded a scholarship to join EnterpriseTECH at Cambridge Judge Business School, served as an Investment Fellow Intern at Syncona, and worked as a Venture Builder Intern at Cambridge Future Tech and OmniBuds, a medical device startup. In these roles, he contributed to early-stage strategy, clinical trial planning, and commercial development. -
Grzegorz Walkiewicz
Postdoctoral Scholar, Ophthalmology
BioGrzegorz (Greg) Walkiewicz, PhD, is a neuroscientist with a strong background in retinal and neurodegenerative disease research. He completed his PhD at KU Leuven (Belgium), focusing on tau pathology and Alzheimer’s disease. His research explores the connection between brain and eye pathology, with particular interest in pTau, Aβ, and microglial activation. He has worked extensively with transgenic mouse models as well as human brain and retinal tissues. He recently joined Stanford University to investigate INPP5K-related mechanisms in retinal ganglion cell degeneration.
-
Wenmin Wang
Postdoctoral Scholar, Ophthalmology
Current Research and Scholarly InterestsI am particularly interested in identifying therapeutic strategies for various eye disorders and investigating the mechanisms by which defects in inositol phosphatases lead to the disruption of primary cilia function and eye diseases by using Omics.